How are immune complexes bound to the primate erythrocyte complement receptor transferred to acceptor phagocytic cells?

Molecular Immunology

Volumn 36, Issue 13-14, 1999, Pages 827-835

  Nardin, Alessandra ^a   Lindorfer, Margaret A ^a   Taylor, Ronald P ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Bispecific antibodies; Complement; Complement receptor 1; Erythrocytes; Immune complexes

Indexed keywords

ANIMAL CELL; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; COMPLEMENT ACTIVATION; COMPLEX FORMATION; CONFERENCE PAPER; CROSS LINKING; IMMUNOTHERAPY; INTERNALIZATION; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIMATE; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECEPTOR BINDING;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY COMPLEX; BIOLOGICAL TRANSPORT, ACTIVE; BLOOD PLATELETS; COMPLEMENT C3B; ERYTHROCYTES; HUMANS; PHAGOCYTES; PRIMATES; RECEPTORS, COMPLEMENT 3B; RECEPTORS, FC;

EID: 0033376409     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(99)00103-0     Document Type: Conference Paper

References (62)

1. Ahearn J.M., Fearon D. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Adv. Immunol. 46:1989;183-219.
2. Bauvois B., Sanceau J., Wietzerbin J. Human U937 cell surface peptidase activities: characterization and degradative effect on tumor necrosis factor. Eur. J. Immunol. 22:1992;923-930.
3. Becker S., Spiess M., Klenk H. The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus. J. Gen. Virol. 76:1995;393-399.
4. Burnie J.P., Matthews R.C. The renaissance of antibody therapy. J. Antimicrob. Chemother. 41:1998;319-322.
5. Chen A., Engel P., Tedder T.F. Structural requirements regulate endoproteolytic release of the L-selectin (CD62L) adhesion receptor from the cell surface of leukocytes. J. Exp. Med. 183:1995;519-530.
6. Connor R.I., Dinces N.B., Howell A.L., Romet-Lemonne J.L., Pasquali J.L., Fanger M.W. Receptors for IgG on human monocytes and macrophages are not infectivity receptors for human immunodeficiency virus type 1: studies using bispecific antibodies to target HIV-1 to various myeloid cell surface molecules including the FcR. Proc. Natl. Acad. Sci. USA. 88:1991;9593-9597.
7. Cornacoff J.B., Hebert L.A., Smead W.L., Van Aman M.E., Birmingham D.J., Waxman F.J. Primate erythrocyte-immune complex-clearing mechanism. J. Clin. Invest. 71:1983;236-247.
8. Cosio F.G., Xiao-Ping S., Birmingham D.J., Van Aman M., Hebert L.A. Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primates. J. Immunol. 145:1990;4198-4206.
9. Davies K.A. Complement, immune complexes and systemic lupus erythematosus. Brit. J. Rheum. 35:1996;5-23.
10. Davies K.A., Hird V., Stewart S., Sivolapenko G.B., Jose P., Epenetos A.A., et al. A study of in vivo immune complex formation and clearance in man. J. Immunol. 144:1990;4613-4620.
11. Davies K.A., Peters M., Beynon H.L., Walport M.J. Immune complex processing in patients with systemic lupus erythematosus. J. Clin. Invest. 90:1992;2075-2083.
12. Edberg J.C., Kimberly R.P., Taylor R.P. Functional characterization of non-human primate erythrocyte immune adherence receptors: implications for the uptake of immune complexes by the cells of the mononuclear phagocytic system. Eur. J. Immunol. 22:1992;1333-1339.
13. Edberg J.C., Kimberly R.P. Receptor specific probes for the study of Fc receptor specific function. J. Immunol. Meth. 148:1992;179-187.
14. Emlen W., Burdick G., Carl V., Lachmann P.J. Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cells. J. Immunol. 142:1989;4366-4371.
15. Emlen W., Carl V., Burdick G. Mechanism of transfer of immune complexes from red blood cell CR1 to monocytes. Clin. Exp. Immunol. 89:1992;8-17.
16. Fauci A.S. Host factors and the pathogenesis of HIV-induced disease. Nature. 384:1996;529-534.
17. Fearon D.T. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte. J. Exp. Med. 152:1980;20-30.
18. Fearon D.T. Human complement receptors for C3b (CR1) and C3 d (CR2). J. Invest. Dermatol. 85:1985;53-57.
19. Ferguson P.J., Reist C.J., Martin E.N., Johnson C., Greene K.L., Kuhn S., et al. Antigen-based heteropolymers: a potential therapy for binding and clearing autoantibodies via erythrocyte CR1. Arth. Rheumat. 38:1995;190-200.
20. Frank M.M. The role of macrophages in bloodstream clearance. Human Monocytes. 1989;337-344 Academic Press, New York.
21. Fremeaux-Bacchi V., Bernard I., Maillet F., Mani J., Fontaine M., Bonnefoy J., et al. Human lymphocytes shed a soluble form of CD21 (the C3dg/Epstein-barr virus receptor, CR2) that binds iC3b and CD23. Eur. J. Immunol. 26:1996;1497-1503.
22. Greenberg S.C.P., Silverstein S.C. Tyrosine phosphorylation is required for Fc receptor-mediated phagocytosis in mouse macrophages. J. Exp. Med. 177:1993;529-534.
23. Hamer I., Paccaud J.-P., Belin D., Maeder C., Carpentier J.-L. Soluble form of complement C3b/C4b receptor (CR1) results from a proteolytic cleavage in the C-terminal region of CR1 transmembrane domain. Biochem. J. 329:1998;183-190.
24. Hermanowski-Vosatka A., Detemers P.A., Gotze O., Silverstein S.C., Wright S.D. Clustering of ligand on the surface of a particle enhances adhesion to receptor-bearing cells. J. Biol. Chem. 263:1988;17,822-17,827.
25. Huizinga T.W.J., de Haas M., Kleijer M., Nuijens J.H., Roos D., von dem Borne A.E.G.Kr. Soluble Fc receptor III in human plasma originates from release by neutrophils. J. Clin. Invest. 86:1990;416-423.
26. Iida K., Mornaghi R., Nussenzweig V. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus. J. Exp. Med. 155:1982;1427-1438.
27. Kane M.A., May J.E., Frank M.M. Interactions of the classical and alternative complement pathway with endotoxin lipopolysaccharide. J. Clin. Invest. 52:1973;370-376.
28. Kimberly R.P., Edberg J.C., Merriam L.T., Clarkson S.B., Unkeless J.C., Taylor R.P. In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees. J. Clin. Invest. 84:1989;962-970.
29. Kohler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 256:1975;495-497.
30. Kuhn S.E., Nardin A., Klebba P.E., Taylor R.P. Escherichia coli bound to the primate erythrocyte complement receptor via bispecific monoclonal antibodies are transferred to and phagocytosed by human monocytes in an in vitro model. J. Immunol. 160:1998;5088-5097.
31. Lach-Trifilieff E., Marfurt J., Schwarz S., Sadallah S., Schifferli J.A. Complement receptor 1 (CD35) on human reticulocytes: normal expression in systemic lupus erythematosus and HIV-infected patients. J. Immunol. 162:1999;7549-7554.
32. Mathison J.C., Ulevitch R.J. The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits. J. Immunol. 123:1979;2133-2143.
33. Mathison J.C., Ulevitch R.J. In vivo interaction of bacterial lipopolysaccharide (LPS) with rabbit platelets: modulation by C3 and high density lipoproteins. J. Immunol. 126:1981;1575-1580.
34. Medof M.E., Prince G.M., Oger J.J.F. Kinetics of interaction of immune complexes with complement receptors on human red blood cells: modification of complexes during interaction with red cells. Clin. Exp. Immunol. 48:1982;715-725.
35. Miller G.W., Steinberg A.D., Green I., Nussenzweig V. Complement-dependent alterations in the handling of immune complexes by NZB/W mice. J. Immunol. 114:1975;1166-1170.
36. Mohler K.M., Sleath P.R., Fitzner J.N., Cerretti D.P., Alderson M., Kerwar S.S., et al. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature. 370:1994;218-220.
37. Montefiori D.C. Role of complement and Fc receptors in the pathogenesis of HIV-1 infection. Springer Semin. Immunopathol. 18:1997;371-390.
38. Mullberg J., Durie F.H., Otten-Evans C., Alderson M.R., Rose-John S., Cosman D., Black R.A., Mohler K.M. A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor. J. Immunol. 155:1995;5198-5205.
39. Multani P.S., Grossbard M.L. Monoclonal antibody-based therapies for hematologic malignancies. J. Clin. Oncol. 16:1999;3691-3710.
40. Nardin A., Schlimgen R., Holers V.M., Taylor R.P. A prototype pathogen bound ex vivo to human erythrocyte complement receptor 1 via bispecific monoclonal antibody complexes is cleared to the liver in a mouse model. Eur. J. Immunol. 29:1999;1581-1586.
41. Nardin A., Sutherland W.M., Hevey M., Schmaljohn A., Taylor R.P. Quantitative studies of heteropolymer-mediated binding of inactivated Marburg virus to the complement receptor on primate erythrocytes. J. Immunol. Meth. 211:1998;21-31.
42. Nelson R.A. The immune-adherence phenomenon. An immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis. Science. 118:1953;733-737.
43. Nelson R.A. The immune-adherence phenomenon. A hypothetical role of erythrocytes in defense against bacteria and viruses. Proc. Roy. Soc. Med. 49:1955;55-58.
44. Newman S.L., Mikus L.K., Tucci M.A. Differential requirements for the cellular cytoskeleton in human macrophage complement receptor and Fc receptor-mediated phagocytosis. J. Immunol. 146:1991;967-974.
45. Pascual M., Danielsson C., Steiger G., Schifferli J.A. Proteolytic cleavage of CR1 on human erythrocytes in vivo: evidence for enhanced cleavage in AIDS. Eur. J. Immunol. 24:1994;702-708.
46. Reinagel M.L., Gezen M., Ferguson P.J., Kuhn S., Martin E.N., Taylor R.P. The primate erythrocyte complement receptor (CR1) as a privileged site. Binding of immunoglobulin G to erythrocyte CR1 does not target erythrocytes for phagocytosis. Blood. 89:1997;1068-1077.
47. Reist C.J., Combs M.J., Croft B.Y., Taylor R.P. Antigens pre-bound to the primate erythrocyte complement receptor via cross-linked bispecific monoclonal antibody heteropolymers are rapidly cleared from the circulation. Eur. J. Immunol. 23:1993;3021-3027.
48. Reist C.J., Liang H.Y., Denny D., Martin E.N., Scheld W.M., Taylor R.P. Cross-linked bispecific monoclonal antibody heteropolymers facilitate the clearance of human IgM from the circulation of squirrel monkeys. Eur. J. Immunol. 24:1994;2018-2025.
49. Ross G.D., Yount W.J., Walport M.J., Winfield J.B., Parker C.J., Fuller C.R., et al. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation. J. Immunol. 135:1985;2005-2014.
50. Ross G.D., Cain J.A., Lachmann P.J. Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin and functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b. J. Immunol. 134:1985;3307-3315.
51. Schifferli J.A., Taylor R.P. Physiological and pathological aspects of circulating immune complexes. Kidney Int. 35:1989;993-1003.
52. Schreiber A.D., Frank M.M. Role of antibody and complement in the immune clearance and destruction of erythrocytes I. In vivo effects of IgG and IgM complement fixing sites. J. Clin. Invest. 51:1972;575-582.
53. Stahl P.D., Ezekowitz R.A.B. The mannose receptor is a pattern recognition receptor involved in host defense. Curr. Opin. Immunol. 10:1998;50-55.
54. Tausk F.A., McCutchan A., Spechko P., Schreiber R.D., Gigli I. Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men: varying risk groups for acquired immune deficiency syndrome. J. Clin. Invest. 78:1986;977-982.
55. Taylor R.P., Sutherland W.M., Martin E.N., Ferguson P.J., Reinagel M.L., Gilbert E., et al. Bispecific monoclonal antibody complexes bound to primate erythrocyte complement receptor 1 facilitate virus clearance in a monkey model. J. Immunol. 158:1997;842-850.
56. Taylor R.P., Martin E.N., Reinagel M.L., Nardin A., Craig M., Choice Q., et al. Bispecific monoclonal antibody complexes facilitate erythrocyte binding and liver clearance of a prototype particulate pathogen in a monkey model. J. Immunol. 159:1997;4035-4044.
57. Taylor R.P., Ferguson P.J., Martin E.N., Cooke J., Greene K.L., Grinspun K., et al. Immune complexes bound to primate erythrocyte complement receptor (CR1) via anti-CR1 mAbs are cleared simultaneously with loss of CR1 in a concerted reaction in a rhesus monkey model. Clin. Immunol. Immunopath. 82:1997;49-59.
58. Taylor R.P., Sutherland W.M., Reist C.J., Webb D.J., Wright E.L., Labuguen R.H. Use of heteropolymeric monoclonal antibodies to attach antigens to the C3b receptor of human erythrocytes: a potential therapeutic treatment. Proc. Natl. Acad. Sci. USA. 88:1991;3305-3309.
59. Victoria J.E., Pierce W.S., Branks J.M., Masouredis S.P. IgG red blood cell autoantibodies in autoimmune hemolytic anemia bind to epitopes on red blood cell membrane band 3 glycoprotein. J. Lab. Clin. Med. 115:1990;74-88.
60. Waldmann T.A., O'Shea J. The use of antibodies against the IL-2 receptor in transplantation. Curr. Opin. Immunol. 10:1999;507-512.
61. Wright S.D. CD14 and innate recognition of bacteria. J. Immunol. 155:1995;6-8.
62. Wright S.D., Jong M.T. Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide. J. Exp. Med. 164:1986;1876-1888.